Cardinal Health Inc
CAH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$132.00 | Szqzgdr | Bsjnrml |
Cardinal Health Ends Fiscal 2023 With Strong Results and Reaffirms Favorable Outlook for 2024
Business Strategy and Outlook
Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $190 billion in annual U.S. drug distribution sales in fiscal year 2023, the company supplies roughly a quarter of the overall market. Its two close competitors are AmerisourceBergen and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.